Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Evelina Miele1, Gian Paolo Spinelli1, Ermanno Miele2, Federica Tomao1, Silverio Tomao11Department of Experimental Medicine, University of Rome “Sapienza”, Rome, Italy; 2Biomedical Engineering, University of Rome Tor Vergata, Rome, ItalyAbstract: Breast cancer is the most...
Main Authors: | Evelina Miele, Gian Paolo Spinelli, Ermanno Miele, Federica Tomao, Silverio Tomao |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-04-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/albumin-bound-formulation-of-paclitaxel-abraxanereg-abi-007-in-the-tre-a3077 |
Similar Items
-
Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane)
by: Naoki Matsuoka, et al.
Published: (2015-01-01) -
Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp.
by: Minzhi Zhao, et al.
Published: (2015-01-01) -
A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
by: Spinelli Gian, et al.
Published: (2006-05-01) -
Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
by: Zullo Angelo, et al.
Published: (2008-10-01) -
The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site
by: Zoratto Federica, et al.
Published: (2008-11-01)